The United Kingdom’s stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and falling commodity prices affecting major companies. Amid these market fluctuations, dividend stocks can offer a measure of stability and income for investors seeking consistent returns. In this article, we will explore three UK dividend stocks, including B.P. Marsh & Partners, that may provide attractive opportunities in the current economic climate.
Top 10 Dividend Stocks In The United Kingdom
|
Name |
Dividend Yield |
Dividend Rating |
|
RS Group (LSE:RS1) |
3.75% |
★★★★★☆ |
|
Multitude (LSE:0R4W) |
8.70% |
★★★★★☆ |
|
MONY Group (LSE:MONY) |
7.24% |
★★★★★★ |
|
Keller Group (LSE:KLR) |
3.17% |
★★★★★☆ |
|
James Halstead (AIM:JHD) |
6.42% |
★★★★★☆ |
|
Impax Asset Management Group (AIM:IPX) |
12.10% |
★★★★★☆ |
|
IG Group Holdings (LSE:IGG) |
3.13% |
★★★★★☆ |
|
Halyk Bank of Kazakhstan (LSE:HSBK) |
12.46% |
★★★★★☆ |
|
Dunelm Group (LSE:DNLM) |
9.13% |
★★★★★☆ |
|
4imprint Group (LSE:FOUR) |
4.72% |
★★★★★☆ |
Click here to see the full list of 46 stocks from our Top UK Dividend Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: B.P. Marsh & Partners PLC invests in early-stage and SME financial services intermediary businesses in the United Kingdom and internationally, with a market cap of £241.61 million.
Operations: B.P. Marsh & Partners PLC generates revenue of £118.87 million from consultancy services and trading investments in financial services.
Dividend Yield: 6.6%
B.P. Marsh & Partners offers a mixed dividend profile. Despite a low payout ratio of 4.9%, indicating dividends are covered by earnings, the absence of free cash flows raises sustainability concerns as dividends aren’t covered by cash flows. Dividend payments have been volatile and unreliable over the past decade, though they have increased overall. Recently, BPM announced a special £2 million dividend for FY 2028 and is actively repurchasing shares, potentially enhancing shareholder value.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Bioventix PLC develops, produces, and distributes sheep monoclonal antibodies for global diagnostic use, with a market cap of £86.21 million.
Operations: Bioventix PLC generates revenue from its biotechnology segment, amounting to £12.54 million.